MTOR and pulmonary arterial hypertension: Preliminary studies from our research showed that knockdown of VPS34 by siRNA in PAVSMC from patients with PAH was associated with increased TSC2 and consequent mTOR inactivation, decreased accumulation of VPS15, and decreased proliferation and survival [20].